Entera Bio Ltd. (ENTX) vs LENZ Therapeutics, Inc. (LENZ)
A side-by-side comparison of Entera Bio Ltd. and LENZ Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ENTX
Entera Bio Ltd.
$2.57HealthcareDelayed quote: Oct 6, 2026, 1:30 PM EDT
LENZ
LENZ Therapeutics, Inc.
$3.72HealthcareDelayed quote: Oct 6, 2026, 1:30 PM EDT
Total return — ENTX vs LENZ
growth of $100 · dividends reinvested · last 5yENTX -56.1% (-15.2%/yr)LENZ -91.4% (-38.7%/yr)ENTX compounded faster over this window
Log scale — wide-divergence pair
ENTX LENZ
ENTX vs LENZ: by the numbers
- •ENTX is the larger company ($127M vs $116M market cap).
- •Both run net losses; LENZ's is the smaller (-586.74% vs -27235.71% net margin).
Metrics side by side
Valuation
| Metric | ENTX | LENZ |
|---|---|---|
| P/S ratio | N/A | 5.42 |
| P/B ratio | 17.41 | 0.53 |
Profitability
| Metric | ENTX | LENZ |
|---|---|---|
| Gross margin | 0.00% | 90.14% |
| Operating margin | -27450.00% | -477.46% |
| Net margin | -27235.71% | -586.74% |
| ROE | -234.42% | -57.47% |
| ROIC | -82.87% | -61.84% |
Growth (annualized)
| Metric | ENTX | LENZ |
|---|---|---|
| Total return CAGR (5Y) | -10.57% | -35.49% |
Frequently asked
- How have ENTX and LENZ total returns compared?
- Over the past 5 years, ENTX delivered -10.57% and LENZ delivered -35.49% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.